Literature DB >> 21102359

Cytoplasmic Ca2+ concentration changes evoked by muscarinic cholinergic stimulation in primary and metastatic melanoma cell lines.

Dénes Nagy1, Lívia Kosztka, Pál Pap, Zsuzsanna Nagy, Zoltán Rusznák, László Csernoch, Géza Szücs.   

Abstract

Experiments were performed to explore differences between cultured primary and metastatic melanoma cell lines in their muscarinic acetylcholine receptor-mediated intracellular Ca signalization. The expression of type 1 and type 3 muscarinic receptors was detected and compared at the protein level using both immunocytochemistry and semiquantitative western blotting. The functionality of muscarinic receptors was tested by applying carbamylcholine (CCh; 1 mmol/l) and by recording the associated increases in cytoplasmic Ca using Ca imaging with the application of the Ca indicator dye, fluo-4. These data indicate that the expression levels of the receptor proteins were not significantly different in the metastatic (HT199, HT168-M1) and the primary (WM35) cell lines. Although Ca transients were evoked in all the three cell lines by CCh, the proportion of the CCh-positive cells was smaller amongst the WM35 cells. The Ca transients could be effectively blocked by atropine (0.1 mmol/l). The time courses of the Ca transients were highly variable, and in some instances they showed a late (plateau-like) component whose presence crucially depended on the influx of extracellular Ca. When the extracellular Ca concentration was reduced, the duration of the CCh-evoked transients was considerably decreased; a phenomenon that was more pronounced in the metastatic cell lines. Although there are no fundamental differences in the muscarinic receptor-mediated Ca signalization of the primary and metastatic cell lines, the quantitative differences showed in this study may partially explain the increased malignancy and migratory potential of the metastatic cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21102359     DOI: 10.1097/CMR.0b013e3283414477

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  Exploring Differential Connexin Expression across Melanocytic Tumor Progression Involving the Tumor Microenvironment.

Authors:  Gergo Kiszner; Peter Balla; Barna Wichmann; Gabor Barna; Kornelia Baghy; Istvan Balazs Nemeth; Erika Varga; Istvan Furi; Bela Toth; Tibor Krenacs
Journal:  Cancers (Basel)       Date:  2019-02-01       Impact factor: 6.639

Review 2.  Role of Muscarinic Acetylcholine Receptors in Breast Cancer: Design of Metronomic Chemotherapy.

Authors:  María E Sales; Alejandro J Español; Agustina R Salem; Paola M Pulido; Y Sanchez; Francisco Sanchez
Journal:  Curr Clin Pharmacol       Date:  2019

Review 3.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.